Chitosan and its derivatives as nanocarriers for siRNA delivery

被引:14
|
作者
Al-Qadi, S. [1 ]
Grenha, A. [2 ]
Remunan-Lopez, C. [1 ]
机构
[1] Univ Santiago de Compostela, Fac Pharm, Dept Pharm & Pharmaceut Technol, Nanobiofar Grp, Santiago De Compostela 15782, Spain
[2] Univ Algarve, IBB Inst Biotechnol & Bioengn, CBME Ctr Mol & Struct Biomed, Faro, Portugal
关键词
Chitosan; Chitosan derivatives; Formulation parameters; Gene silencing; Nanocarriers; siRNA delivery; SMALL INTERFERING RNA; TARGETED GENE DELIVERY; NUCLEIC-ACID DELIVERY; MOLECULAR-WEIGHT; IN-VITRO; DRUG-DELIVERY; ANTISENSE OLIGONUCLEOTIDES; ANTIINFLAMMATORY TREATMENT; NANOPARTICLE FORMULATION; INTRAVENOUS DELIVERY;
D O I
10.1016/S1773-2247(12)50003-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability to specifically silence genes using siRNA has enormous potential for treating genetic diseases. However, siRNA instability and biodistribution issues still need to be overcome, and adequate delivery vehicles have proven indispensable in conveying siRNA to its target. Chitosan is a promising biopolymer for siRNA delivery, its interest stemming from its solely, biodegradability, mucoadhesivity, permeation enhancing effect and cationic charge, as well as amenability to undergo chemical modifications. Chitosan and its derivatives can be readily arranged into complexes or nanoparticles able to entrap and carry siRNA. Specific strategies have been adopted to improve chitosan-based vectors with regard to transfectability. However, further efforts cure required to verify their value and adapt them to enhance therapeutic output prior to clinical application. This review emphasizes the potential of chitosan and its derivatives to develop nanocarriers for siRNA delivery. The properties of chitosan that are significant for transfectability and the most relevant findings are assessed.
引用
收藏
页码:29 / 42
页数:14
相关论文
共 50 条
  • [41] In vivo delivery of siRNA to tumours and their vasculature by novel dendritic nanocarriers
    Ofek, P.
    Fischer, W.
    Calderon, M.
    Haag, R.
    Satchi-Fainaro, R.
    EJC SUPPLEMENTS, 2010, 8 (05): : 53 - 54
  • [42] Non-viral nanocarriers for siRNA delivery in breast cancer
    Zhang, Jing
    Li, Xiang
    Huang, Leaf
    JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 440 - 450
  • [43] Modularized Gold Nanocarriers for TAT-Mediated Delivery of siRNA
    Huang, Xiao
    Lai, Yifan
    Braun, Gary B.
    Reich, Norbert O.
    SMALL, 2017, 13 (08)
  • [44] Glycerol Monooleate-Based Nanocarriers for siRNA Delivery in Vitro
    Zhen, Guoliang
    Hinton, Tracey M.
    Muir, Benjamin W.
    Shi, Shuning
    Tizard, Mark
    McLean, Keith M.
    Hartley, Patrick G.
    Gunatillake, Pathiraja
    MOLECULAR PHARMACEUTICS, 2012, 9 (09) : 2450 - 2457
  • [45] Nanocarriers for siRNA Delivery Aimed at the Treatment of Melanoma: Systematic Review
    de Araujo, Brenda Regina
    do Nascimento, Tatielle
    dos Santos Matos, Ana Paula
    de Souza Belmiro, Vanessa Brandao
    de Bustamante Monteiro, Mariana Sato de Souza
    Santos-Oliveira, Ralph
    Ricci-Junior, Eduardo
    CURRENT DRUG DELIVERY, 2023,
  • [46] Nanocarriers in effective pulmonary delivery of siRNA: current approaches and challenges
    Bardoliwala, Denish
    Patel, Vivek
    Javia, Ankit
    Ghosh, Saikat
    Patel, Akanksha
    Misra, Ambikanandan
    THERAPEUTIC DELIVERY, 2019, 10 (05) : 311 - 332
  • [47] Non-viral nanocarriers for siRNA delivery in breast cancer
    Zhang, Jing
    Li, Xiang
    Huang, Leaf
    Journal of Controlled Release, 2014, 190 : 440 - 450
  • [48] Development and characterisation of chitosan nanoparticles for siRNA delivery
    Katas, Haliza
    Alpar, H. Oya
    JOURNAL OF CONTROLLED RELEASE, 2006, 115 (02) : 216 - 225
  • [49] Chitosan-based siRNA delivery systems
    Ragelle, Heloise
    Vandermeulen, Gaelle
    Preat, Veronique
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) : 207 - 218
  • [50] Oligoarginine-modified chitosan for siRNA delivery
    Park, Soyeon
    Lee, Sang Kyung
    Lee, Kuen Yong
    JOURNAL OF CONTROLLED RELEASE, 2011, 152 : E165 - E166